Xiaofang Che

4.9k citations
158 papers · 3.6k indexed · h-index 35
Topics
RNA modifications and cancer (21 papers)Cancer-related molecular mechanisms research (20 papers)MicroRNA in disease regulation (18 papers)
Journals
Nature CommunicationsJournal of Clinical OncologySHILAP Revista de lepidopterología
Partner nations
ChinaJapanUnited States

In The Last Decade

Xiaofang Che

151 papers receiving 3.6k citations

Peers

Xiaofang Che
Comparison fields: 5 of 125
  • Molecular Biology 2.2k
  • Cancer Research 1.2k
  • Oncology 1.2k
  • Immunology 600
  • Pulmonary and Respiratory Medicine 533
Replace Rongcheng Luo with:
Rongcheng Luo China
Kezuo Hou China
Jichun Zhou China
Jinfang Zhang China
Jingxuan Pan China
Kuen‐Feng Chen Taiwan
Xiujuan Qu China
Hua‐chuan Zheng China
Tarek Abbas United States
Wei‐Fen Xie China
Xiaofang Che relative to Rongcheng Luo China Rongcheng Luo's profile →
Citations per field
00.5×1.5×
Rongcheng Luo · 1×
Citations per year

Countries citing papers authored by Xiaofang Che

Since Specialization
Citations

This map shows the geographic impact of Xiaofang Che's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofang Che with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofang Che more than expected).

Fields of papers citing papers by Xiaofang Che

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofang Che. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofang Che. The network helps show where Xiaofang Che may publish in the future.

Co-authorship network of co-authors of Xiaofang Che

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofang Che. A scholar is included among the top collaborators of Xiaofang Che based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofang Che. Xiaofang Che is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 4
4 1
5 12
6 13
7 9
8 11
9 6
10 13
11 50
12 29
13 46
14 24
15 10
16 12
17 33
18 53
19 60
20 63

About Xiaofang Che

Xiaofang Che is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 158 papers that have together received 3.6k indexed citations. Recurring topics across this work include RNA modifications and cancer (21 papers), Cancer-related molecular mechanisms research (20 papers) and MicroRNA in disease regulation (18 papers). The work is most often cited by research in Cancer Research (1.2k citations), Oncology (1.2k citations) and Molecular Biology (2.2k citations). Xiaofang Che has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Xiujuan Qu, Kezuo Hou, Yunpeng Liu, Yibo Fan, Ce Li, Zhi Li, Ti Wen, Ling Xu, Yunpeng Liu and Chunlei Zheng. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026